A Repository of Atria Tissue for the Investigation of Atrial Pathophysiology in Patients with Atrial Fibrillation


About this study

The purpose of this study is to collect surgically removed atrial tissue for genetic, pathologic, metabolic, and molecular studies in patients with or without a history of atrial fibrillation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria

  • A history of documented atrial fibrillation who undergo cardiac surgery for valvular heart disease or coronary artery disease with concomitant MAZE procedure
  • A history of documented atrial fibrillation including post-operative AF undergoing cardiac surgery without MAZE procedure
  • A history of atrial fibrillation undergoing cardiac surgery (controls)
  • Heart transplant recipients with AF or without AF (controls)
  • All above willing to donate surgically removed atrial tissue to the study

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Yong-Mei Cha, M.D.

Open for enrollment

Contact information:

Jonathan Furuseth



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer